Clinical and Biochemical Characteristics in PCOS Women With Menstrual Abnormalities
- PMID: 28546817
- PMCID: PMC5440817
Clinical and Biochemical Characteristics in PCOS Women With Menstrual Abnormalities
Abstract
Objective: The purpose of the present study was to examine the impact of menstrual cycle abnormalities among patients with polycystic ovary syndrome (PCOS) on biochemical and anthropometric characteristics. Materials and methods: We conducted a prospective observational study of patients 17-35 years of age with PCOS that attended the department of Gynecological Endocrinology of our hospital. Results: A total of 309 women with PCOS participated in the study. In total, 72.2% suffered from menstrual cycle disorders. In our study 15.1% of women were overweight and 24% were obese. Also, 36% of the sample had androgenetic alopecia and 56.4% had acne. According to the stepwise discriminant analysis, we observed that glucose displayed the strongest association to the menstrual status (F to eliminate = 14.13), followed by endometrial thickness (F to eliminate = 10.89), waist circumference (F to eliminate = 10.17), LH levels (F to eliminate = 8.15) and PRL (F to eliminate = 4.45). Significantly higher levels of LH and TSH and lower levels of prolactin were found in women with menstrual disorders compared to those with normal menstrual cycles. Fasting glucose was also considerably higher among these patients although markers of insulin resistance such as the Matsuda, Quicki and HOMA-IR indices did not differ. Conclusion: According to the findings of our study PCOS patients with menstrual disorders exhibit hormonal alterations and elevated fasting glucose. Future studies are needed in this field to corroborate our findings and determine the anthropometric and biochemical profile of patients with menstrual cycle irregularities.
Keywords: Anovulation; Glucose Intolerance; Menstrual Disorders; PCOS.
Similar articles
-
Subclinical hypothyroidism does not influence the metabolic and hormonal profile of women with PCOS.Horm Mol Biol Clin Investig. 2017 Jun 23;31(3):/j/hmbci.2017.31.issue-3/hmbci-2016-0058/hmbci-2016-0058.xml. doi: 10.1515/hmbci-2016-0058. Horm Mol Biol Clin Investig. 2017. PMID: 28672734
-
Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: a prospective controlled study.J Am Acad Dermatol. 2013 Dec;69(6):922-30. doi: 10.1016/j.jaad.2013.09.014. Epub 2013 Oct 11. J Am Acad Dermatol. 2013. PMID: 24120563
-
Visceral adiposity index (VAI) is related to the severity of anovulation and other clinical features in women with polycystic ovary syndrome.Clin Endocrinol (Oxf). 2014 Sep;81(3):426-31. doi: 10.1111/cen.12447. Epub 2014 Apr 15. Clin Endocrinol (Oxf). 2014. PMID: 24601936
-
[Exploration of the classification of polycystic ovarian syndrome].Zhonghua Fu Chan Ke Za Zhi. 2006 Oct;41(10):684-8. Zhonghua Fu Chan Ke Za Zhi. 2006. PMID: 17199924 Chinese.
-
[Body composition and polycystic ovary syndrome].Medicina (Kaunas). 2010;46(2):142-57. Medicina (Kaunas). 2010. PMID: 20440089 Review. Lithuanian.
Cited by
-
Correlation of Serum Prolactin Levels With Metabolic and Cardiovascular Risk in Greek Women With Polycystic Ovarian Syndrome.Cureus. 2024 May 1;16(5):e59430. doi: 10.7759/cureus.59430. eCollection 2024 May. Cureus. 2024. PMID: 38826895 Free PMC article.
-
Characterizing Genetic, Epigenetic, Nutritional, and Clinico-Biochemical Profile of Women With Polycystic Ovary Syndrome: A Case-Control Study.J Nutr Metab. 2025 May 30;2025:8817919. doi: 10.1155/jnme/8817919. eCollection 2025. J Nutr Metab. 2025. PMID: 40486662 Free PMC article.
-
Identifying a causal link between prolactin signaling pathways and COVID-19 vaccine-induced menstrual changes.NPJ Vaccines. 2023 Sep 1;8(1):129. doi: 10.1038/s41541-023-00719-6. NPJ Vaccines. 2023. PMID: 37658087 Free PMC article.
-
Association of childhood dehydroepiandrosterone sulfate concentration, pubertal development, and DNA methylation at puberty-related genes.Eur J Endocrinol. 2024 Nov 27;191(6):623-635. doi: 10.1093/ejendo/lvae156. Eur J Endocrinol. 2024. PMID: 39670713
-
Glycemic Index and Glycemic Load Estimates in the Dietary Approach of Polycystic Ovary Syndrome.Nutrients. 2023 Aug 7;15(15):3483. doi: 10.3390/nu15153483. Nutrients. 2023. PMID: 37571420 Free PMC article. Review.
References
-
- Ma YM, Li R, Qiao J, Zhang XW, Wang SY, Zhang QF, Li L, Tu BB, Zhang X. Characteristics of abnormal menstrual cycle and polycystic ovary syndrome in community and hospital populations. Chin Med J (Engl) 2010;123:2185–9. - PubMed
-
- Bouzas IC, Cader SA, Leao L, Kuschnir MC, Braga C. Menstrual cycle alterations during adolescence: early expression of metabolic syndrome and polycystic ovary syndrome. J Pediatr Adolesc Gynecol. 2014;27:335–41. - PubMed
-
- Pinola P, Lashen H, Bloigu A, Puukka K, Ulmanen M, Ruokonen A, et al. Menstrual disorders in adolescence: a marker for hyperandrogenaemia and increased metabolic risks in later life? Finnish general population-based birth cohort study. Hum Reprod. 2012;27:3279–86. - PubMed
-
- Strowitzki T, Capp E, von Eye Corleta H. The degree of cycle irregularity correlates with the grade of endocrine and metabolic disorders in PCOS patients. Eur J Obstet Gynecol Reprod Biol. 2010;149:178–81. - PubMed
-
- Xu XH, Tan YC, Shi YH, Wang B, Ju XQ, Zheng QM, et al. Different types of menstrual cycle and their significance in Chinese women diagnosed with polycystic ovary syndrome according to the Rotterdam consensus criteria] Zhonghua Yi Xue Za Zhi. 2009;89:2604–6. - PubMed
LinkOut - more resources
Full Text Sources
Medical